Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Paschka

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Susan P Whitman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B StudyPeter Paschka, Guido Marcucci, Amy S Ruppert, et al.
Haematologica|October 4, 2017
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemiaSusanne Hirsch, Tamara J Blätte, Sarah Grasedieck, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Nature Genetics|January 17, 2017
Precision oncology for acute myeloid leukemia using a knowledge bank approachMoritz Gerstung, Elli Papaemmanuil, Inigo Martincorena, et al.
Leukemia|October 3, 2019
Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)Tatjana Meyer, Nikolaus Jahn, Stefanie Lindner, et al.
Blood|June 13, 2019
NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemiaAlina Rudorf, Tony Andreas Müller, Cathrin Klingeberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study groupVerena I Gaidzik, Peter Paschka, Daniela Späth, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Blood|March 8, 2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B studySusan P Whitman, Amy S Ruppert, Guido Marcucci, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Susan P Whitman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B StudyPeter Paschka, Guido Marcucci, Amy S Ruppert, et al.
Haematologica|October 4, 2017
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemiaSusanne Hirsch, Tamara J Blätte, Sarah Grasedieck, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Nature Genetics|January 17, 2017
Precision oncology for acute myeloid leukemia using a knowledge bank approachMoritz Gerstung, Elli Papaemmanuil, Inigo Martincorena, et al.
Leukemia|October 3, 2019
Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)Tatjana Meyer, Nikolaus Jahn, Stefanie Lindner, et al.
Blood|June 13, 2019
NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemiaAlina Rudorf, Tony Andreas Müller, Cathrin Klingeberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study groupVerena I Gaidzik, Peter Paschka, Daniela Späth, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Blood|March 8, 2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B studySusan P Whitman, Amy S Ruppert, Guido Marcucci, et al.
Pageof 8